Subscribe

Alison Little, KPMG

Articles by Alison Little, KPMG

Is your corporate board equipped to monitor incentive programs?

ByBy Regina Cavaliere,Alison Little, KPMG

May 22nd 2017

Compliance officers at pharma companies need to ensure that the right mechanisms are in place for monitoring sales and business incentives

Latest Updated Articles

Is your corporate board equipped to monitor incentive programs?
May 22nd 2017

Trending on Pharmaceutical Commerce

TrumpRx Adds 160 More Drugs: Why the Latest Expansion Matters

How AI and CGTs Are Reshaping Pharma 3PL

FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?

Danny Williams on What the Next Five Years Hold for Pharma 3PLs

FAQ: The Medicare GLP-1 Bridge Program